Italia

Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076, currently in phase i clinical development

Menarini Ricerche today announced the publication of the results of a non-clinical study...

Menarini: Elcin Barker Ergun Group CEO

The Board of Directors has appointed Mrs. Elcin Barker Ergun as CEO of Menarini Group

First67891011121315

i nostri valori

4 valori, che hanno dato vita a Menarini e ne hanno forgiato la storia. 

LEGGI TUTTO »